Xyphos Biosciences and Gladstone Institutes Announce Publication Demonstrating convertibleCAR? Cells and Bispecific Broadly Neutralizing Antibodies Reduce Latent HIV Reservoir

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Xyphos Biosciences, Inc. and Gladstone Institutes today announced the publication of key preclinical data demonstrating that convertibleCAR? cells attack and significantly reduce latent reservoirs of diverse HIV strains. These latent reservoirs persist even in patients taking antiretroviral therapy (ART) and are a major barrier to a cure for HIV/AIDS. The publication, ?Attacking Latent HIV with convertibleCAR cells, a Highly Adaptable Killing Platfo